Ambu A/S (CPH:AMBU.B)
107.10
+0.80 (0.75%)
At close: Oct 23, 2025
Ambu A/S Market Cap
Ambu A/S has a market cap or net worth of 28.53 billion as of October 24, 2025. Its market cap has decreased by -16.10% in one year.
Market Cap
28.53B
Enterprise Value
28.31B
Revenue
5.96B
Ranking
n/a
PE Ratio
79.82
Stock Price
107.10
Market Cap Chart
Since August 8, 1994, Ambu A/S's market cap has increased from 290.04M to 28.53B, an increase of 9,736.75%. That is a compound annual growth rate of 15.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 28.69B | 3.56% |
| Dec 30, 2024 | 27.70B | -1.11% |
| Dec 29, 2023 | 28.01B | 23.89% |
| Dec 30, 2022 | 22.61B | -48.49% |
| Dec 30, 2021 | 43.90B | -32.73% |
| Dec 30, 2020 | 65.26B | 138.06% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.53T |
| Coloplast | 135.64B |
| Genmab | 118.18B |
| Demant | 50.31B |
| ALK-Abelló | 47.29B |
| H. Lundbeck | 43.48B |
| Zealand Pharma | 32.17B |
| Bavarian Nordic | 18.92B |